Cargando…

Recent progress in the intranasal PLGA-based drug delivery for neurodegenerative diseases treatment

One of the most challenging problems of the current treatments of neurodegenerative diseases is related to the permeation and access of most therapeutic agents to the central nervous system (CNS), prevented by the blood-brain barrier (BBB). Recently, intranasal (IN) delivery has opened new prospects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aghaei Delche, Nasim, Kheiri, Reyhaneh, Ghorbani Nejad, Behnam, Sheikhi, Mojgan, Razavi, Malihe Sadat, Rahimzadegan, Milad, Salmasi, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510483/ https://www.ncbi.nlm.nih.gov/pubmed/37736505 http://dx.doi.org/10.22038/IJBMS.2023.70192.15264

Ejemplares similares

Comparison of Memory Impairment and Oxidative Stress Following Single or Repeated Doses Administration of Scopolamine in Rat Hippocampus
por: Rahimzadegan, Milad, et al.
Publicado: (2018)

Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
por: Kosyakovsky, Jacob, et al.
Publicado: (2021)

PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
por: Cunha, Anthony, et al.
Publicado: (2021)

Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds
por: Razavi, Malihe Sadat, et al.
Publicado: (2022)

Targeted delivery of galbanic acid to colon cancer cells by PLGA nanoparticles incorporated into human mesenchymal stem cells
por: Ebrahimian, Mahboubeh, et al.
Publicado: (2022)

Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma
por: Manni, Luigi, et al.
Publicado: (2021)

Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
por: Bi, Chenchen, et al.
Publicado: (2016)

Hierarchical Porous Carbon—PLLA and PLGA Hybrid Nanoparticles for Intranasal Delivery of Galantamine for Alzheimer’s Disease Therapy
por: Nanaki, Stavroula G., et al.
Publicado: (2020)

Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration
por: Wang, Siqi, et al.
Publicado: (2022)

The relationship between use of complementary and alternative medicine and health literacy in chronically ill outpatient cases: a cross-sectional study in southeastern Iran
por: Dehghan, Mahlagha, et al.
Publicado: (2023)

Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
por: El-Hammadi, Mazen M., et al.
Publicado: (2022)

The Recent Applications of PLGA-Based Nanostructures for Ischemic Stroke
por: Yan, Jun, et al.
Publicado: (2023)

Recent advances in the formulation of PLGA microparticles for controlled drug delivery
por: Lagreca, Elena, et al.
Publicado: (2020)

Effect of Topical Furosemide Efficacy on Reducing Bleeding and Quality of Surgical Field During Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis
por: Jahanshahi, Javaneh, et al.
Publicado: (2022)

Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders
por: Rassu, Giovanna, et al.
Publicado: (2018)

Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases
por: Su, Yu, et al.
Publicado: (2020)

Intranasal midazolam sedation as an effective sedation route in pediatric patients for radiologic imaging in the emergency ward: A single-blind randomized trial
por: Mayel, Masoud, et al.
Publicado: (2020)

PLGA Based Drug Carrier and Pharmaceutical Applications: The Most Recent Advances
por: Loureiro, Joana Angélica, et al.
Publicado: (2020)

Recent advances in preventing neurodegenerative diseases
por: Chou, Shih-Ching, et al.
Publicado: (2021)

Manganese‐induced parkinsonism responsive to intranasal insulin: A case report
por: Salari, Mehri, et al.
Publicado: (2022)

Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves
por: Mansoor, Fawad, et al.
Publicado: (2015)

Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases
por: Torres, Joana, et al.
Publicado: (2023)

Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
por: Duong, Van-An, et al.
Publicado: (2023)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
por: Su, Yue, et al.
Publicado: (2021)

Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
por: Meng, Qingqing, et al.
Publicado: (2018)

Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles
por: Chung, Eugene P., et al.
Publicado: (2020)

Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice
por: Umeda, Tomohiro, et al.
Publicado: (2021)

Anticancer Activity of Nanoparticles Based on PLGA and its Co-polymer: In-vitro Evaluation
por: Amjadi, Issa, et al.
Publicado: (2013)

"APP"reciating the complexity of HIV-induced neurodegenerative diseases
por: Naghavi, Mojgan H.
Publicado: (2018)

Editorial: Lipid-protein interactions and regulation in neurodegenerative disorders
por: Haddadi, Mohammad, et al.
Publicado: (2023)

Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology
por: Anand, Bibin, et al.
Publicado: (2022)

Recent advances utilized in artificial switchable catalysis
por: Ghorbani-Choghamarani, Arash, et al.
Publicado: (2022)

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
por: Crowe, Tyler P., et al.
Publicado: (2022)

Intranasal Delivery of Cationic PLGA Nano/Microparticles- Loaded FMDV DNA Vaccine Encoding IL-6 Elicited Protective Immunity against FMDV Challenge
por: Wang, Gang, et al.
Publicado: (2011)

Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease
por: Musumeci, Teresa, et al.
Publicado: (2022)

DPD simulations on morphologies and structures of blank PLGA-b-PEG-b-PLGA polymeric micelles and docetaxel-loaded PLGA-b-PEG-b-PLGA polymeric micelles
por: Wang, Mengyao, et al.
Publicado: (2022)

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
por: Hanson, Leah R, et al.
Publicado: (2008)

The anti-diabetic and antioxidant effects of a combination of Commiphora mukul, Commiphora myrrha and Terminalia chebula in diabetic rats
por: Sotoudeh, Reyhaneh, et al.
Publicado: (2019)

In-vitro Study of Multifunctional PLGA-SPION Nanoparticles Loaded with Gemcitabine as Radiosensitizer Used in Radiotherapy
por: Hamzian, Nima, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d5ofhnhidir1rl2ctb147b1jec